No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16‐week open‐label trial

OBJECTIVE: To examine the potential therapeutic effect of methotrexate 20 mg given weekly as subcutaneous injections to 20 patients with ankylosing spondylitis refractory to non‐steriodal antirheumatic drugs. PATIENTS AND METHODS: 20 patients with ankylosing spondylitis, a mean Bath Ankylosing Spond...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Haibel, H, Brandt, H C, Song, I H, Brandt, A, Listing, J, Rudwaleit, M, Sieper, J
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2007
Assuntos:
Concise Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1856012/
https://ncbi.nlm.nih.gov/pubmed/16901959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.054098
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados